نتائج البحث - "Robert L. Dobbins"

المساهمون: Tytgat Institute for Liver and Intestinal Research, Gastroenterology and Hepatology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism

المصدر: Lancet, 389(10074), 1114-1123. Elsevier Limited

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cholangitis, Thiazepines, Placebo, Gastroenterology, law.invention, 03 medical and health sciences, Methylamines, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Ileum, Internal medicine, medicine, Humans, Adverse effect, skin and connective tissue diseases, Cholestatic pruritus, Cross-Over Studies, Membrane Glycoproteins, business.industry, Liver Cirrhosis, Biliary, Pruritus, General Medicine, Middle Aged, medicine.disease, Crossover study, Ursodeoxycholic acid, Surgery, Clinical trial, Treatment Outcome, Tolerability, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, business, Carrier Proteins, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464c43763c14fc0ad022460ae7d576c8Test
https://doi.org/10.1016/s0140-6736Test(17)30319-7

8

BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial

المؤلفون: Sam R. Miller, Vinod S. Hegade, Susan Vallow, Robert L. Dobbins, George E. Dukes, Margaret Corrigan, James Storey, Duncan Richards, Stuart Kendrick, David Jones, Graeme J.M. Alexander, Gideon M. Hirschfield, Kim Gilchrist

المصدر: BMC Gastroenterology

مصطلحات موضوعية: Male, 0301 basic medicine, Cholagogues and Choleretics, Thiazepines, PBC, Gastroenterology, law.invention, Study Protocol, 0302 clinical medicine, Primary biliary cirrhosis, Randomized controlled trial, law, Ileal bile acid transporter, skin and connective tissue diseases, Enterohepatic circulation, Cholestatic pruritus, Cross-Over Studies, Symporters, Bile acid, Liver Cirrhosis, Biliary, Ursodeoxycholic Acid, General Medicine, Middle Aged, Ursodeoxycholic acid, Tolerability, Drug Therapy, Combination, Female, 030211 gastroenterology & hepatology, medicine.drug, Adult, medicine.medical_specialty, Adolescent, medicine.drug_class, Organic Anion Transporters, Sodium-Dependent, Bile Acids and Salts, Methylamines, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, Aged, IBAT, business.industry, Pruritus, Primary biliary cholangitis, medicine.disease, Crossover study, 030104 developmental biology, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2234c33fb3df880594322de63a1a2aTest
https://ora.ox.ac.uk/objects/uuid:75a2d000-7488-4c92-bfb2-399cc1427faeTest

9

Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release

المؤلفون: Yaping Liu, Lihong Chen, Frank L. Greenway, Robert L. Dobbins, Chari D. Smith, Susan Andrews, Jeffrey A. Wald, Ann C. Walker, Sharon L Breed

المصدر: American Journal of Physiology-Gastrointestinal and Liver Physiology. 308:G946-G954

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Physiology, Administration, Oral, Biological Availability, Gastric Inhibitory Polypeptide, Gastric inhibitory peptide, Glucose absorption, Sodium-Glucose Transporter 1, Glucosides, Glucagon-Like Peptide 1, Physiology (medical), Internal medicine, Intestine, Small, medicine, Animals, Humans, Insulin, Intestinal Mucosa, Dose-Response Relationship, Drug, Hepatology, Chemistry, digestive, oral, and skin physiology, Gastroenterology, Glucose transporter, Translation (biology), Middle Aged, Rats, Glucose-Dependent Insulinotropic Peptide, Glucose, Treatment Outcome, Endocrinology, Intestinal Absorption, SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1, 3-O-Methylglucose, Pyrazoles, Female, Drug Monitoring

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2fd76e344ef5f98ec3265dbb6372922Test
https://doi.org/10.1152/ajpgi.00286.2014Test

10

Randomized trial showing efficacy and safety of twice-daily remogliflozin etabonate for the treatment of type 2 diabetes

المؤلفون: L. Kler, D. J. Dorey, W. O. Wilkison, S. Walker, Robert L. Dobbins, Robin L. O'Connor-Semmes, A. P. Sykes, J. D. Lorimer

المصدر: Diabetes, Obesity and Metabolism. 17:94-97

مصطلحات موضوعية: medicine.medical_specialty, Patient Dropouts, Endocrinology, Diabetes and Metabolism, Remogliflozin etabonate, Urology, Type 2 diabetes, Placebo, Drug Administration Schedule, law.invention, chemistry.chemical_compound, Endocrinology, Double-Blind Method, Glucosides, Randomized controlled trial, law, Membrane Transport Modulators, Weight Loss, Internal Medicine, Clinical endpoint, Humans, Hypoglycemic Agents, Medicine, Prodrugs, Sodium-Glucose Transporter 2 Inhibitors, Glycated haemoglobin, Glycated Hemoglobin, Hypertriglyceridemia, Dose-Response Relationship, Drug, Pioglitazone, business.industry, Middle Aged, medicine.disease, Hypoglycemia, Intention to Treat Analysis, Surgery, Diabetes Mellitus, Type 2, Tolerability, chemistry, Hyperglycemia, Pyrazoles, Thiazolidinediones, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51226f4d7f15c5ffab9fe84e2cbd26c6Test
https://doi.org/10.1111/dom.12391Test

تنقيح النتائج